Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

autologous tumor infiltrating lymphocytes LN-145

A proprietary preparation of autologous tumor infiltrating lymphocytes (TILs), with potential immunomodulating activity. The autologous TILs are isolated from an autologous tumor sample and expanded ex vivo in the presence of interleukin-2 (IL-2). Upon infusion of the autologous TILs LN-145 back into the patient, the cells specifically recognize, target and kill the patient's tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:autologous TILs LN-145
autologous tumor-infiltrating lymphocytes LN-145
Code name:LN-145
LN145
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search